Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

Contact
Request a demo
Request data updates
Add a company

Research

Companies
Investors
People

aVenture

Sitemap
Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage

Loading

Loading

Jan Garfinkle

AddedMar 31, 2024

UpdatedMay 31, 2026

Jan Garfinkle

Jan Garfinkle

Board Member, National Venture Capital Association

Crunchbase LinkedIn

Jan Garfinkle's Career

National Venture Capital Association

National Venture Capital Association

Washington, D.C., DC, US

Board Member· Board

Arboretum Ventures

Arboretum Ventures

Ann Arbor, MI, US

Co-Founder

Koya Medical

Oakland, CA, US

Board Member· Board

Francis Medical

Francis Medical

Maple Grove, MN, US

Board Member· Board

Sonitus Medical

Sonitus Medical

San Mateo, CA, US

Board Member· Board

Baronova

Goleta, CA, US

Board Member· Board

Strata Oncology

Strata Oncology

Ann Arbor, MI, US

Board Member· Board

RareCyte

Seattle, WA, US

Board Member· Board

Cardiac Dimensions

Cardiac Dimensions

Kirkland, WA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Jan Garfinkle's Career

National Venture Capital Association

National Venture Capital Association

NonprofitNonprofit721982Washington, D.C., DC, US

Board Member· Board

Recent news

a16z spends $1.49M in Washington lobbying, while rivals mostly sit outTechCrunch · 2025

Leadership at National Venture Capital Association

Nick WashburnBoard Member

Vic ParkerBoard Member

Rob KettersonBoard Member

Jennifer TeganBoard Member

Niten MalhanBoard Member

Mark KloppBoard Member

Similar to National Venture Capital Association

Venture for AmericaNew York City, NY, USest. 2011Venture for AmericaNew York City, NY, US · est. 2011

Venture for America: A non-profit fostering economic growth in US cities through entrepreneurship training.

VentureWellHadley, MA, USTrainingest. 1995VentureWellHadley, MA, US · est. 1995

VentureWell: Funding, training, and catalyzing student-led ventures for social and environmental impact.

Activation CapitalRichmond, VA, USInnovation Programsest. 1993Activation CapitalRichmond, VA, US · est. 1993

Empowering innovation and talent in Richmond's ecosystem.

Nonprofit · $15M3

Western New York Venture AssociationBuffalo, NY, USBusiness, Investmentest. 1989Western New York Venture AssociationBuffalo, NY, US · est. 1989

WNY Venture Association: Promoting business and investment opportunities in Western New York.

Arboretum Ventures

Arboretum Ventures

Investment FirmInvestment Firm$5M222002Ann Arbor, MI, US

Co-Founder

Leadership at Arboretum Ventures

Tim PetersenCo-Founder

Stephane MouradianBoard Member

Kirk MalloyBoard Member

Andrew CleelandBoard Member

Similar to Arboretum Ventures

Arbor VenturesSingapore, Singapore, SGest. 2013Arbor VenturesSingapore, Singapore, SG · est. 2013

Arbor Ventures: A visionary VC investing in early-stage FinTech, shaping global transactions.

Investment Firm18

Venture InvestorsMadison, WI, USest. 1997Venture InvestorsMadison, WI, US · est. 1997

Venture Investors LLC: A US-based venture capital firm specializing in healthcare and technology sectors.

Investment Firm18

30VenturesMadison, WI, USest. 201830VenturesMadison, WI, US · est. 2018

30Ventures: A Midwest-based venture capital firm specializing in early-stage healthcare and biotech innovations.

Investment Firm2

Arbor PartnersAnn Arbor, MI, USest. 1996Arbor PartnersAnn Arbor, MI, US · est. 1996

Arbor Partners L.L.C.: A US-based venture capital firm investing in enterprise software, semiconductors, and advanced materials.

Investment Firm8

Koya Medical

Series C$70.2M942018Oakland, CA, US

Board Member· Board

Leadership at Koya Medical

Ali BauerleinBoard Member

Andy DoraiswamyFounder & CEO

Josh BaltzellBoard Member

Francis Medical

Francis Medical

Series B$77M422018Maple Grove, MN, US

Board Member· Board

Leadership at Francis Medical

Michael HoeyBoard Member

Andre De BruinBoard Member

Michael R KujakCEO

Dave AdairBoard Member

David S Masarek MBABoard Member

Sonitus Medical

Sonitus Medical

Seed$74.2M752006San Mateo, CA, US

Board Member· Board

Leadership at Sonitus Medical

Amir AbolfathiBoard Member

Mark FoleyBoard Member

Peter H R RiepenhausenBoard Member

Similar to Sonitus Medical

Soundwave HearingOak Brook, IL, USHearing Aids, Softwareest. 2017Soundwave HearingOak Brook, IL, US · est. 2017

Soundwave Hearing: A health tech firm developing smart hearing aids using machine learning.

Series A · $2.3M9

Sonitus TechnologiesSan Mateo, CA, USCommunication Devicesest. 2010Sonitus TechnologiesSan Mateo, CA, US · est. 2010

Sonitus Technologies provides innovative wireless communication devices, enabling real-time monitoring in challenging environments.

Series A · $11.8M30

Sonogen MedicalChevy Chase, MD, USMedical Devicesest. 2020Sonogen MedicalChevy Chase, MD, US · est. 2020

Sonogen Medical: Innovating ultrasonic devices for accelerated bone fracture healing and real-time feedback.

Seed · $245.7k4

SonicSurg InnovationsLakeland, FL, USMedical Devicesest. 2009SonicSurg InnovationsLakeland, FL, US · est. 2009

SonicSurg Innovations: Florida-based medical device developer for treating trigger finger and broken bones.

Baronova

Series A$85.9M752006Goleta, CA, US

Board Member· Board

Recent news

Invesco raises its valuation of Swiggy to $13.3BTechCrunch · 2024

Leadership at Baronova

Gerry BrunkBoard Member

Rob KuhlingBoard Member

Daniel BalbierzBoard Member

Hugh NarcisoFounder

Daniel BurnettBoard Member

Strata Oncology

Strata Oncology

Series C$128M902016Ann Arbor, MI, US

Board Member· Board

Leadership at Strata Oncology

Dan RhodesCo-Founder

Dan KidleBoard Member

Keith FlahertyCo-Founder

Scott TomlinsCo-Founder

Nicole J WalkerBoard Member

Similar to Strata Oncology

OncoPrecisionNew York City, NY, USCancer Treatmentest. 2020OncoPrecisionNew York City, NY, US · est. 2020

Developing advanced tech for personalized cancer treatment and aiding in transformative therapy creation.

Seed · $4.2M37

GenomOncologyCleveland, OH, USHealthcare, Softwareest. 2012GenomOncologyCleveland, OH, US · est. 2012

GenomOncology: Transforming data into actionable insights for improved cancer care.

Pre-Seed · $2.9M62

Onc.AISan Carlos, CA, USOncology Softwareest. 2020Onc.AISan Carlos, CA, US · est. 2020

Creating precision oncology software for clinical use, with a focus on physician-centered products.

Series A · $31M30

Certis Oncology SolutionsSan Diego, CA, USOncology Solutionsest. 2016Certis Oncology SolutionsSan Diego, CA, US · est. 2016

Certis Oncology Solutions: Precision-care provider for individualized patient care since 2016.

Series C · $10M74

RareCyte

Public$76M782009Seattle, WA, US

Board Member· Board

Leadership at RareCyte

Andy SchwabBoard Member

Brian DanielsBoard Member

Frank WitneyBoard Member

Daniel R. MarshakBoard Member

Joseph VictorBoard Member

David S. KabakoffBoard Member

Cardiac Dimensions

Cardiac Dimensions

Public$209.7M622001Kirkland, WA, US

Board Member· Board

Leadership at Cardiac Dimensions

Gregory CasciaroBoard Member

Nathan EveryBoard Member

Trevor MoodyBoard Member

Renee RyanBoard Member

Mark MathisFounder

Fouad AzzamBoard Member

Jan Garfinkle's Similar Executives & Operators

Nugroho HerucahyonoCo-Founder · Bukalapak

Soemantri BrodjonegoroBoard Member · Bukalapak

Lau Eng BoonBoard Member · Bukalapak

Achmad ZakyCo-Founder · Bukalapak

Jay Geoffrey WacherBoard Member · Bukalapak

Chi-hyung SongBoard Member · Dunamu

Haeil YiCo-Founder · Dunamu

Hyoung-nyon KimCo-Founder · Dunamu

People Similar to Jan Garfinkle

Michael B GormanCo-Founder · Split Rock Partners

Sunil NagarajFounder · Ubiquity Ventures

Arthur PattersonCo-Founder · Accel

Fred WangBoard Member · Exalt Communications

Gavin ChristensenFounder · Kickstart